硫脲类阴离子受体的设计合成与阴离子识别

硫脲类化合物具有生物活性,是优良的氢键供体,与阴离子特别是含氧阴离子形成氢键配合物。本文设计合成了系列二苯基硫脲衍生物,通过取代基效应调控硫脲衍生物分子内电转移过程,阴离子与硫脲基团结合后,增强了分子内供体的给电子能力,进一步促进电荷转移过程,据此识别不同的阴离子。由于主体分子与阴离子间形成氢键的能力及阴离子碱性的差异,可达到选择性结合的目的。     

新型超分子化合物C6H20N2O64P2MO18·8H2O 的晶体结构及电催化作用

多酸是较好的受体分子,当它与有机电子给体作用时,可形成超分子化合物.90年代初这类化合物的研究才刚刚起步.作为一类新型电、磁、非线性光学材料极具开发价值[1].用氨基酸作为电子给体对生物活性研究意义重大[2],有关Keggin结构的超分子化合物已见报道[3],但标题化合物这类手性阴离子[4]与手性氨基酸所形成的杂多化合物及单晶结构尚未见文献报道.     

多足开链化合物与阴离子的相互作用

设计合成了６种萘取代的脲及硫脲类多足开链化合物，利用吸收光谱、荧光光谱及_１Ｈ ＮＭＲ波谱手段详细研究了该类化合物作为主体分子与不同种类的阴离子客体分子间的相互作用．实验表明，客体阴离子Ｈ_２ＰＯ_４~－及ＨＳＯ_４~－可以与三足的脲及硫脲主体分子形成主客体配合物从而诱导主体分子光物理性质发生变化，而且表现出较好的选择性．测定了主客体配合物的稳定常数和化学配位比，对三足脲和硫脲与阴离子客体的选择性和识别作用进行了比较，提出了相应主客体配合物可能的配位方式和结构形式．     

钒-药物分子配合物生物活性研究进展

无机钒化合物具有降血糖、抗癌、抗炎和抗菌等作用,但生物利用度低,且有一定的毒性,影响了其在药物领域的应用。选择药物分子作为钒的配体,不仅可提高钒化合物的生物利用度,而且可增强或改进药物分子的活性,同时可能降低钒的毒性,从而成为近年来钒化学领域一个新的研究方向。本文主要介绍钒与不同类型药物分子形成配合物的生物活性及相关工作。     

5-嘧啶基-1,2,4-噁二唑衍生物的合成及生物活性研究

通过嘧啶甲酰氯与取代的苄胺肟反应得到一系列结构新颖的5-嘧啶基-1,2,4-噁二唑类化合物,并对其结构进行了表征,培养并测定了化合物5a的晶体结构;将目标化合物晶体结构对接到靶酶酵母乙酰辅酶A羧化酶(ACCase)的活性位点,发现目标化合物与复合物晶体中的禾草灵分子的构象及结合模式相似;初步生物活性测试表明部分化合物具有较好的除草活性.     

硼酸及其衍生物在荧光分子开关中的应用

荧光分子开关中主体和客体之间可以通过多种方式相结合，其中带有荧光团的硼酸衍生物与糖或羟基化合物的结合是通过共价键形成的。糖化学在生命科学中起着非常重要的作用，因此对糖的识别和检测在医学、细胞生物学等领域具有至关重要的意义。硼酸衍生物可以作为荧光分子开关对糖进行有效的选择性识别，因而受到科学家们的广泛关注。本文对近年来国内外相关研究成果进行了综述。     

新型的水溶性氮杂对环吩类主体化合物的合成

新型的水溶性氮杂对环吩类主体化合物的合成张秀莲尹伟（广东教育学院化学系广州５１０３０３）梅盛开周茂青（西北大学化学系西安７１００６９）超分子化学是一个蓬勃发展的化学新领域，它主要研究分子识别、分子弱化学作用［１］。环糊精是研究较多的主体化合物，但由于...     

L-α-二油酸磷酯酰胆碱和芦丁硬脂酸酯混合单分子膜的相容性

黄酮类化合物广泛存在于植物中,具有抗氧化、抗肿瘤和抗病毒等多种生物活性[1-3]。许多研究表明,具有相同苷元的黄酮类化合物比其糖苷具有更优秀的抗氧化活性,这是由于苷元亲脂性强能嵌入生物膜流水层的内核发挥作用,以及糖基的空间位阻减弱了黄酮化合物和生物分子的结合能力[4     

杯芳烃对生物活性分子的识别性能*

杯芳烃是一类由苯酚和甲醛缩合而成的大环化合物,由于杯芳烃的上沿和下沿容易进行化学修饰及其本身具有一个大小可调节的疏水空腔,使得杯芳烃对客体分子表现出特殊的识别能力.本文就杯芳烃对氨基酸、糖、肽链、蛋白质等生物活性分子及手性药物的分子识别作一综述.     

杂环烯酮缩胺:构筑分子多样性稠杂环化合物的合成先导分子

杂环烯酮缩胺（HKAs）是一类构建分子多样性稠杂环化合物的多功能合成砌块,已被广泛应用于构筑多种多样的类天然杂环化合物和合成药物中。随着杂环烯酮缩胺研究的深入开展,其作为双亲核试剂与多种亲电底物反应取得了较大的进展。本文将基于HKAs的结构特征、反应性能,对以HKAs及1,1-烯二胺为合成子构建各种类型具有潜在生物活性的类天然多环稠杂环化合物进行综述。     

HPTLC Quantification and Antimicrobial Activity of Ursolic Acid from Diospyros melanoxylon

JPC – Journal of Planar Chromatography – Modern TLC - An important bioactive molecule, ursolic acid was isolated from the leaves of Diospyros melanoxylon and characterized with help of...     

Lewis Acid–Base Interaction‐Controlled ortho‐Selective C−H Borylation of Aryl Sulfides

An iridium/bipyridine‐catalyzed ortho ‐selective C−H borylation of aryl sulfides was developed. High ortho ‐selectivity was achieved by a Lewis acid–base interaction between a boryl group of the ligand and a sulfur atom of the substrate. This is the first example of a catalytic and regioselective C−H transformation controlled by a Lewis acid–base interaction between a ligand and a substrate. The C−H borylation reaction could be conducted on a gram scale, and with a bioactive molecule as a substrate, demonstrating its applicability to late‐stage regioselective C−H borylation. A bioactive molecule was synthesized from an ortho ‐borylated product by converting the boryl and methylthio groups of the product.     

Solubilization of nutraceuticals into reverse hexagonal mesophases

The solubilization of four bioactive molecules with different polarities, in three reverse hexagonal (HII) systems has been investigated. The three HII systems were a typical reverse hexagonal composed of glycerol monooleate (GMO)/tricaprylin/water and two fluid hexagonal systems containing either 2.75 wt % Transcutol or ethanol as a fourth component. The phase behavior of the liquid crystalline phases in the presence of ascorbic acid, ascorbyl palmitate, D-alpha-tocopherol and D-alpha-tocopherol acetate were determined by small-angle X-ray scattering (SAXS) and optical microscopy. Differential scanning calorimetry (DSC) and Fourier-transform infrared (FT-IR) techniques were utilized to follow modifications in the thermal behavior and in the vibrations of different functional groups upon solubilizing the bioactive molecules. The nature of each guest molecule (in both geometry and polarity) together with the different HII structures (typical and fluids) determined the corresponding phase behavior, swelling or structural transformations and its location in the HII structures. Ascorbic acid was found to act as a chaotropic guest molecule, localized in the water-rich core and at the interface. The AP was also a chaotropic guest molecule with its head located in the vicinity of the GMO headgroup while its tail embedded close to the surfactant tail. D-alpha-tocopherol and D-alpha-tocopherol acetate were incorporated between the GMO tails; however, the D-alpha-tocopherol was located closer to the interface. Once Transcutol or ethanol was present and upon guest molecule incorporation, partial migration was detected.     

A robust force field based method for calculating conformational energies of charged drug-like molecules

The binding affinity of a drug-like molecule depends among other things on the availability of the bioactive conformation. If the bioactive conformation has a significantly higher energy than the global minimum energy conformation, then the molecule is unlikely to bind to its target. Determination of the global minimum energy conformation and calculation of conformational penalties of binding is a prerequisite for prediction of reliable binding affinities. Here, we present a simple and computationally efficient procedure to estimate the global energy minimum for a wide variety of structurally diverse molecules, including polar and charged compounds. Identifying global energy minimum conformations of such compounds with force field methods is problematic due to the exaggeration of intramolecular electrostatic interactions. We demonstrate that the global energy minimum conformations of zwitterionic compounds generated by conformational analysis with modified electrostatics are good approximations of the conformational distributions predicted by experimental data and with molecular dynamics performed in explicit solvent. Finally the method is used to calculate conformational penalties for zwitterionic GluA2 agonists and to filter false positives from a docking study.     

A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists

Summary In the absence of a 3D structure of the target biomolecule, to propose the 3D requirements for a small molecule to exhibit a particular bioactivity, one must supply both a bioactive conformation and a superposition rule for every active compound. Our strategy identifies both simultaneously. We first generate and optimize all low-energy conformations by any suitable method. For each conformation we then use ALAD-DIN to calculate the location of points to be considered as part of the superposition. These points include atoms in the molecule and projections from the molecule to hydrogen-bond donors and acceptors or charged groups in the binding site. These positions and the relative energy of each conformation are the input to our new program DISCO. It uses a clique-detection method to find superpositions that contain a least one conformation of each molecule and user-specified numbers of point types and chirality. DISCO is fast; for example, it takes about 1 min CPU to propose pharmacophores from 21 conformations of seven molecules. We typically run DISCO several times to compare alternative pharmacophore maps. For D₂ dopamine agonists DISCO shows that the newer 2-aminothiazoles fit the traditional pharmacophore. Using site points correctly identifies the bioactive enantiomers of indoles to compare with catechols whereas using only ligand points leads to selecting the inactive enantiomer for the pharmacophore map. In addition, DISCO reproduces pharmacophore maps of benzodiazepines in the literature and proposes subtle improvements. Our experience suggests that clique-detection methods will find many applications in computational chemistry and computer-assisted molecular design.     

Simplexidine, a 4-alkylpyridinium alkaloid from the Caribbean sponge Plakortis simplex

Chemical analysis of the secondary metabolites of the Caribbean sponge Plakortis simplex, a source of many bioactive compounds, showed the presence of the new metabolite simplexidine (4), belonging to the extremely rare class of 4-alkyl-pyridinium alkaloids. The structural characterization of this molecule, based on spectroscopic methods, is reported.     

Investigations into the Aqueous Synthesis of Selenoglycoconjugates

Glycosylation of bioactive molecules has been found to improve the pharmacokinetic properties of the parent molecule. However, their syntheses often require tedious protecting group manipulations. The development of methodologies which allow direct aqueous conversion of unprotected sugars into glycosides is therefore an ambitious goal. Herein, we present a broadly applicable method for the synthesis of selenoglycosides in water. We show the ease of direct conjugation of unprotected glycosyl diselenides with various biomolecules, including resorcinol, resveratrol, and the antitumor agent, gimeracil, furnishing the corresponding selenoglycoconjugates in up to 96 % yield. We also demonstrate the oxidatively-triggered release of the bioactive drug from the sugar, priming these molecules for medicinal applications. The generality and broad substrate scope of this novel transformation will provide access to various selenium-containing glycomimetics and glycoconjugates.